IGC Pharma, Inc. (IGC)
0.3074
0.00 (0.00%)
USD |
NYAM |
Aug 26, 14:38
IGC Pharma Profit Margin (Quarterly) : -1.11K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.11K% |
| March 31, 2026 | -757.7% |
| December 31, 2025 | -207.4% |
| September 30, 2025 | -953.4% |
| June 30, 2025 | -487.5% |
| March 31, 2025 | -477.0% |
| December 31, 2024 | |
| September 30, 2024 | -416.7% |
| June 30, 2024 | -874.3% |
| March 31, 2024 | -978.0% |
| December 31, 2023 | -2.74K% |
| September 30, 2023 | -842.3% |
| June 30, 2023 | -373.9% |
| March 31, 2023 | -2.43K% |
| December 31, 2022 | -677.4% |
| September 30, 2022 | -1.21K% |
| June 30, 2022 | -1.31K% |
| March 31, 2022 | -5.33K% |
| December 31, 2021 | -1.68K% |
| September 30, 2021 | -7.76K% |
| June 30, 2021 | -2.32K% |
| March 31, 2021 | -3.64K% |
| December 31, 2020 | -2.15K% |
| September 30, 2020 | -1.33K% |
| June 30, 2020 | -322.3% |
| Date | Value |
|---|---|
| March 31, 2020 | -10.88K% |
| December 31, 2019 | -279.8% |
| September 30, 2019 | -64.74% |
| June 30, 2019 | -83.63% |
| March 31, 2019 | -102.3% |
| December 31, 2018 | -89.34% |
| September 30, 2018 | -105.8% |
| June 30, 2018 | -34.67% |
| March 31, 2018 | -50.32% |
| December 31, 2017 | -69.95% |
| September 30, 2017 | -129.0% |
| June 30, 2017 | -817.6% |
| March 31, 2017 | -824.3% |
| December 31, 2016 | -29.20% |
| September 30, 2016 | -363.1% |
| June 30, 2016 | -124.9% |
| March 31, 2016 | -102.0% |
| December 31, 2015 | -41.01% |
| September 30, 2015 | -31.15% |
| June 30, 2015 | -19.02% |
| March 31, 2015 | -86.81% |
| December 31, 2014 | -23.56% |
| September 30, 2014 | -43.25% |
| June 30, 2014 | -158.4% |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.01K% |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 67.84% |
| Fulcrum Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -116.5% |
| Return on Assets | -85.56% |
| Return on Invested Capital | -108.4% |
| Gross Profit Margin (Quarterly) | 2.64% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -102.0% |